Literature DB >> 2835813

HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

J A Zack1, A J Cann, J P Lugo, I S Chen.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) are two distinct human retroviruses that infect T cells. Recent epidemiologic studies have identified a cohort of individuals that are coinfected with both viruses. It is reported here that human peripheral blood leukocytes infected with HIV-1 in vitro can be induced to produce large quantities of HIV-1 after mitogenic stimulation by noninfectious HTLV-I virions. It is also shown that HTLV-I virions may exert this effect prior to, immediately following, or well after the cells are infected with HIV-1. These results provide further impetus for epidemiologic studies of dually infected individuals to determine whether HTLV-I may act as a cofactor for acquired immunodeficiency syndrome (AIDS).

Entities:  

Mesh:

Year:  1988        PMID: 2835813     DOI: 10.1126/science.2835813

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

1.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

2.  OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Authors:  Y Takahashi; Y Tanaka; A Yamashita; Y Koyanagi; M Nakamura; N Yamamoto
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  A cooperative interaction of human T-cell leukemia virus type 1 Tax with the p21 cyclin-dependent kinase inhibitor activates the human immunodeficiency virus type 1 enhancer.

Authors:  S F Parker; N D Perkins; S D Gitlin; G J Nabel
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.

Authors:  M D Dodon; A Bernard; L Gazzolo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells.

Authors:  T M Ross; M Narayan; Z Y Fang; A C Minella; P L Green
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.

Authors:  E Böhnlein; M Siekevitz; D W Ballard; J W Lowenthal; L Rimsky; H Bogérd; J Hoffman; Y Wano; B R Franza; W C Greene
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.

Authors:  N Manca; A Caruso; C Bonfanti; E Savoldi; R Li Vigni; F Pirali; P L Sapelli; A Turano
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

9.  Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.

Authors:  V Maguer; H Cassé-Ripoll; L Gazzolo; M D Dodon
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.